Skip to main content
Clinical Trials/NCT03901443
NCT03901443CompletedNot Applicable

Survey on Itch in Outpatients of a University Clinic

University Hospital, Basel, Switzerland1 site in 1 country300 target enrollmentStarted: December 9, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
itch perception

Study Overview

Brief Summary

This study is to investigate the pruriception (i.e. the perception of the character and intensity of itch), the impact of itch on quality of life, the response to itch and the subjective efficacy and preferences of the different treatment options among patients with different skin diseases. Better insights into these aspects might help to optimize itch treatment in clinical Settings.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • outpatients suffering from itch

Exclusion Criteria

  • outpatients (suffering from itch) not willing or able to participate

Outcomes

Primary Outcomes

itch perception

Time Frame: single time point assessment at baseline

Questions regarding situations in which the itch is especially bad (multiple choice options regarding day time, daily situations, season); objective assessment in which respondents are asked to select answers from the choices offered as a list

quality of sleep

Time Frame: single time point assessment at baseline

Questions regarding sleep disturbance by itch (Does itch disturb the patient's sleep and/or sleep of other persons? (yes/no))

days missing at work

Time Frame: single time point assessment at baseline

Approximate number of days missing at work due to itch within last 6 months

helpfulness of common itch therapies

Time Frame: single time point assessment at baseline

Questions regarding helpfulness of common itch therapies (NRS 0-10; 0 = no reduction in itch, 10 = complete reduction of itch; additionally free text options to indicate specific creams, tablets or alternative medicine)

itch intensity

Time Frame: single time point assessment at baseline

Questions regarding itch perception (NRS 0-10; 0 = no itch, 10 = worst imaginable itch) experienced at the moment, within the last 7 days, within the last month

impact of itch on quality of life

Time Frame: single time point assessment at baseline

Questions regarding strength of impact of itch on quality of life (NRS 0-10; 0 = no impact, 10 = extreme)

preferred treatment options

Time Frame: single time point assessment at baseline

Questions regarding preferred treatment options (NRS 0- 10; 0 = unimportant, 10 = most important; including additional free text option)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Basel, Switzerland
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials